Apellis Pharmaceuticals | 10-Q:2024财年三季报
Apellis Pharmaceuticals | 4:持股变动声明-高管 Francois Cedric
Apellis Pharmaceuticals | SC 13G:超过5%持股股东披露文件-BlackRock, Inc.(5.1%)
Apellis Pharmaceuticals | 4:持股变动声明-高管 Watson David O.
Apellis Pharmaceuticals | 4:持股变动声明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股变动声明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股变动声明-高管 Chopas James George
Apellis Pharmaceuticals | 144:拟议出售证券
Apellis Pharmaceuticals | 4:持股变动声明-高管 Chopas James George
Apellis Pharmaceuticals | 144:拟议出售证券
Apellis Pharmaceuticals | 4:持股变动声明-高管 DeLong Mark Jeffrey
Apellis Pharmaceuticals | 8-K:重大事件
Apellis Pharmaceuticals | 10-Q:2024财年二季报
Apellis Pharmaceuticals | 4:持股变动声明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 4:持股变动声明-董事 Dunlop A. Sinclair
Apellis Pharmaceuticals | 144:拟议出售证券
Apellis Pharmaceuticals | 8-K:重大事件
Apellis Pharmaceuticals | 4:持股变动声明-高管 Deschatelets Pascal
Apellis Pharmaceuticals | 8-K:重大事件
Apellis Pharmaceuticals | 4:持股变动声明-高管 Deschatelets Pascal
暂无数据
暂无数据